This brand name is authorized in Estonia, Israel, Lithuania
The drug BACLOSAL contains one active pharmaceutical ingredient (API):
|
1
Baclofen
UNII H789N3FKE8 - BACLOFEN
|
|
Baclofen depresses monosynaptic and polysynaptic reflex transmission, probably by stimulating the GABAB-receptors. This stimulation in turn inhibits the release of the excitatory amino acids glutamate and aspartate. Neuromuscular transmission is unaffected by baclofen. Baclofen also exerts an antinociceptive effect. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M03BX01 | Baclofen | M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1429433, 1429444 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 2231, 2232, 9161, 9377 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004642, 1004643 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
